title: The beneficial effect of trazodone treatment on escitalopram-associated nocturnal bruxism.
authors.affiliation: Sha'ar Menashe Mental Health Center Affiliated to the Rappaport Faculty of Medicine Israel Institute of Technology Haifa, Israel alexander.grinshpoon@sm.health.gov.il Felsenstein Medical Research Center and Geha Mental Health Center Petah Tiqva, Israel and Sackler Faculty of Medicine Tel-Aviv University Tel Aviv, Israel Sha'ar Menashe Mental Health Center Affiliated to the Rappaport Faculty of Medicine Israel Institute of Technology Haifa, Israel.
authors.forename: Alexander
authors.initials: A
authors.lastname: Grinshpoon
authors.forename: Abraham
authors.initials: A
authors.lastname: Weizman
authors.forename: Avi
authors.initials: A
authors.lastname: Amrami-Weizman
mesh_terms: D000328:Adult; D015283:Citalopram / Q000009:adverse effects*; D006801:Humans; D008297:Male; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D020186:Sleep Bruxism / Q000139:chemically induced* / Q000188:drug therapy*; D014196:Trazodone / Q000627:therapeutic use*
chemical_list: D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors; D014196:Trazodone